Publication Date:
2013-08-08
Description:
Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia Leukemia 27, 1769 (August 2013). doi:10.1038/leu.2013.37 Authors: S E M Herman, P M Barr, E M McAuley, D Liu, A Wiestner & J W Friedberg
Print ISSN:
0887-6924
Electronic ISSN:
1476-5551
Topics:
Medicine
Permalink